Melexis N.V.
MLXSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.93 | 3.14 | 0.28 | 0.36 |
| FCF Yield | 4.31% | -2.27% | 5.36% | 2.48% |
| EV / EBITDA | 11.63 | 13.77 | 9.93 | 21.43 |
| Quality | ||||
| ROIC | 23.01% | 29.07% | 37.94% | 32.04% |
| Gross Margin | 43.03% | 45.65% | 44.81% | 42.50% |
| Cash Conversion Ratio | 1.04 | 0.01 | 0.95 | 1.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.71% | 14.42% | 18.11% | 9.76% |
| Free Cash Flow Growth | 236.29% | -162.03% | 43.44% | 45.43% |
| Safety | ||||
| Net Debt / EBITDA | 0.71 | 0.49 | -0.30 | -0.16 |
| Interest Coverage | 19.60 | 43.65 | 447.35 | 279.95 |
| Efficiency | ||||
| Inventory Turnover | 2.02 | 2.06 | 2.57 | 2.56 |
| Cash Conversion Cycle | 177.10 | 167.14 | 146.17 | 149.03 |